H. Lee Moffitt Cancer Center & Research Institute

Physician, Faculty, and Staff

Jonathan R. Strosberg, MD

Jonathan R. Strosberg, MD

Faculty Rank:

Assistant Member

Titles:

Department/Program Affiliations:

  • Experimental Therapeutics  
  • Gastrointestinal Tumor  

Primary Address:

H. Lee Moffitt Cancer Center &
Research Institute
12902 Magnolia Drive
Tampa, FL 33612

Consultation/Referral Phone:

(813) 745-7257

USF Affiliations/College Department:

  • Medicine / Oncologic Sciences
  • Medicine / Internal Medicine

University Academic Rank:

Assistant Professor

For corrections, please e-mail a request

Printer friendly version
Printer friendly version (including publications)

Jonathan R. Strosberg, MD

Education & Training:

  • B.A., Harvard University, 1995
  • M.D., Cornell University Medical College, 1999
  • Residency, Georgetown University Hospital, 2001 - General Internal Medicine
  • Fellowship, H. Lee Moffitt Cancer Center & Research Institute, 2006 - Medical Oncology & Hematology

General Board Certification / SubSpecialty:

  • Internal Medicine / Hematology
  • Internal Medicine / Medical Oncology

For corrections, please e-mail a request

Printer friendly version
Printer friendly version (including publications)

Jonathan R. Strosberg, MD

Research Interests:

Phase 2 trials in neuroendocrine cancers, specifically carcinoid and pancreatic endocrine tumors focusing on biologic targeted therapy.


Clinical Interests:

Neuroendorine malignancies, specifically carcinoid tumors and pancreatic endocrine (islet cell) tumors.

For corrections, please e-mail a request

Printer friendly version
Printer friendly version (including publications)

Jonathan R. Strosberg, MD

Publications:

  1. Anthony LB, Strosberg JR, Klimstra DS, Maples WJ, O'Dorisio TM, Warner RR, Wiseman GA, Benson AB, Pommier RF. The NANETS Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Neuroendocrine Tumors (NETs): Well-Differentiated NETs of the Distal Colon and Rectum. Pancreas. 2010 Aug;39(6):767-774. Pubmedid: 20664474.   Pubmed ID: 20664474

  2. Barthel JS, Kucera ST, Lin JL, Hoffe SE, Strosberg JR, Ahmed I, Dilling TJ, Stevens CW. Does Barrett's esophagus respond to chemoradiation therapy for adenocarcinoma of the esophagus?. Gastrointest Endosc. 2010 Feb;71(2):235-240. Pubmedid: 20003971.   Pubmed ID: 20003971

  3. Phan AT, Oberg K, Choi J, Harrison LH, Hassan MM, Strosberg JR, Krenning EP, Kocha W, Woltering EA, Maples WJ. NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Well-Differentiated Neuroendocrine Tumors of the Thorax (Includes Lung and Thymus). Pancreas. 2010 Aug;39(6):784-798. Pubmedid: 20664476.   Pubmed ID: 20664476

  4. Strosberg J, Kvols L. Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors. World J Gastroenterol. 2010 Jun;16(24):2963-2970. Pubmedid: 20572298.   Pubmed ID: 20572298

  5. Strosberg JR, Coppola D, Klimstra DS, Phan AT, Kulke MH, Wiseman GA, Kvols LK. The NANETS Consensus Guidelines for the Diagnosis and Management of Poorly Differentiated (High-Grade) Extrapulmonary Neuroendocrine Carcinomas. Pancreas. 2010 Aug;39(6):799-800. Pubmedid: 20664477.   Pubmed ID: 20664477

  6. Clark OH, Benson AB, Berlin JD, Choti MA, Doherty GM, Engstrom PF, Gibbs JF, Heslin MJ, Kessinger A, Kulke MH, Kvols L, Salem R, Saltz L, Shah MH, Shibata S, Strosberg JR, Yao JC. NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors. J Natl Compr Canc Netw. 2009 Jul;7(7):712-747. Pubmedid: 19635226.   Pubmed ID: 19635226

  7. Kvols LK, Turaga KK, Strosberg J, Choi J. Role of interventional radiology in the treatment of patients with neuroendocrine metastases in the liver. J Natl Compr Canc Netw. 2009 Jul;7(7):765-772. Pubmedid: 19635229.   Pubmed ID: 19635229

  8. Strosberg J, Gardner N, Kvols L. Survival and prognostic factor analysis in patients With metastatic pancreatic endocrine carcinomas. Pancreas. 2009 Apr;38(3):255-258. Pubmedid: 19066493.   Pubmed ID: 19066493

  9. Strosberg J, Gardner N, Kvols L. Survival and prognostic factor analysis of 146 metastatic neuroendocrine tumors of the mid-gut. Neuroendocrinology. 2009 Jan;89(4):471-476. Pubmedid: 19174605.   Pubmed ID: 19174605

  10. Strosberg J, Nasir A, Coppola D, Wick M, Kvols L. Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors. Hum Pathol. 2009 Sep;40(9):1262-1268. Pubmedid: 19368957.   Pubmed ID: 19368957

  11. Hodul P, Strosberg J, Kvols L. Aggressive surgical resection in the management of pancreatic neuroendocrine tumors: when is it indicated. Cancer Control. 2008 Oct;15(4):314-321. Pubmedid: 18813199.   Pubmed ID: 18813199

  12. Nasir A, Gardner N, Strosberg J, Ahmad N, Choi J, Malafa M, Coppola D, Kwekkeboom D, Teunissen J, Kvols L. Multimodality management of a polyfunctional pancreatic endocrine carcinoma with markedly elevated serum vasoactive intestinal polypeptide and calcitonin levels. Pancreas. 2008 Apr;36(3):309-313. Pubmedid: 18362846.   Pubmed ID: 18362846

  13. Strosberg JR, Nasir A, Hodul P, Kvols L. Biology and treatment of metastatic gastrointestinal neuroendocrine tumors. Gastrointest Cancer Res. 2008 May;2(3):113-125. Pubmedid: 19259290.   Pubmed ID: 19259290

  14. Strosberg J, Hoffe S, Gardner N, Choi J, Kvols L. Effective treatment of locally advanced endocrine tumors of the pancreas with chemoradiotherapy. Neuroendocrinology. 2007;85(4):216-220. Pubmedid: 17541257.   Pubmed ID: 17541257

  15. Strosberg J, Kvols L. A review of the current clinical trials for gastroenteropancreatic neuroendocrine tumours. Expert Opin Investig Drugs. 2007 Feb;16(2):219-224. Pubmedid: 17243941.   Pubmed ID: 17243941

  16. Strosberg J, Nasir A, Cragun J, Gardner N, Kvols L. Metastatic carcinoid tumor to the ovary: A clinicopathologic analysis of seventeen cases. Gynecol Oncol. 2007 Jul;106(1):65-8. Pubmedid: 17475313.   Pubmed ID: 17475313

  17. Strosberg JR, Shibata D, Kvols LK. Intermittent bowel obstruction due to a retained wireless capsule endoscope in a patient with a small bowel carcinoid tumour. Can J Gastroenterol. 2007 Feb;21(2):113-115. Pubmedid: 17299616.   Pubmed ID: 17299616

  18. Nasir A, Stridsberg M, Strosberg J, Su P, Livingston S, Malik H, Kelley ST, Centeno B, Coppola D, Malafa M, Yeatman T, Kvols L. Somatostatin receptor profiling in hepatic metastases from small intestinal and pancreatic neuroendocrine neoplasms: immunohistochemical approach with potential clinical utility. Cancer Control. 2006 Jan;13(1):52-60. Pubmedid: 16508627.   Pubmed ID: 16508627

  19. Osborne D, Zervos E, Strosberg J, Boe B, Malafa M, Rosemurgy A, Yeatman TJ, Carey L, Duhaine L, Kvols L. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors. Ann Surg Oncol. 2006 Apr;13(4):572-581. Pubmedid: 16511671.   Pubmed ID: 16511671

  20. Strosberg J, Choi J, Cantor A, Kvols L. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors. Cancer Control. 2006 Jan;13(1):72-78. Pubmedid: 16508629.   Pubmed ID: 16508629

Jonathan R. Strosberg, MD

Below is a list of active grants where the faculty member is the Principal Investigator. Grants are sorted by sponsor and then sorted by start date, with the more recent grant shown first.

Phase II Trial of ARQ 197 in Second Line HCC
Sponsor: ArQule, Inc.
Project Dates: November 30, 2009 to November 29, 2011
Earned to Date: $11,000

Physician/Faculty  Contact Form

© Copyright 1996 - 2010 H. Lee Moffitt Cancer Center & Research Institute